CHS Inc. (CHSCN) Stock Competitors & Peer Comparison
See (CHSCN) competitors and their performances in Stock Market.
Peer Comparison Table: Agricultural Farm Products Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| CHSCN | $25.19 | +0.02% | 309.5M | N/A | N/A | +7.28% |
| ADM | $82.82 | -1.53% | 40.2B | 37.22 | $2.24 | +2.47% |
| BG | $128.80 | -1.99% | 25.1B | 34.06 | $3.80 | +2.17% |
| TSN | $58.43 | +2.35% | 20.3B | 44.80 | $1.27 | +3.55% |
| SFD | $26.87 | +4.54% | 10.4B | 10.28 | $2.57 | +4.30% |
| AGRO | $11.82 | -3.04% | 6.8B | 605.00 | $0.02 | +2.44% |
| CALM | $74.99 | -0.47% | 3.5B | 5.18 | $14.37 | +6.44% |
| IBA | $53.00 | -1.82% | 2.6B | 7.77 | $6.82 | +1.84% |
| FDP | $29.75 | +0.81% | 1.4B | 20.26 | $1.45 | +4.07% |
| DOLE | $13.85 | +0.54% | 1.3B | 14.99 | $0.93 | +2.45% |
Stock Comparison
CHSCN vs ADM Comparison June 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 309.5M. In comparison, ADM has a market cap of 40.2B. Regarding current trading prices, CHSCN is priced at $25.19, while ADM trades at $82.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas ADM's P/E ratio is 37.22. In terms of profitability, CHSCN's ROE is +0.05%, compared to ADM's ROE of +0.05%. Regarding short-term risk, CHSCN is less volatile compared to ADM. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check ADM's competition here
CHSCN vs BG Comparison June 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 309.5M. In comparison, BG has a market cap of 25.1B. Regarding current trading prices, CHSCN is priced at $25.19, while BG trades at $128.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas BG's P/E ratio is 34.06. In terms of profitability, CHSCN's ROE is +0.05%, compared to BG's ROE of +0.05%. Regarding short-term risk, CHSCN is less volatile compared to BG. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check BG's competition here
CHSCN vs TSN Comparison June 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 309.5M. In comparison, TSN has a market cap of 20.3B. Regarding current trading prices, CHSCN is priced at $25.19, while TSN trades at $58.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas TSN's P/E ratio is 44.80. In terms of profitability, CHSCN's ROE is +0.05%, compared to TSN's ROE of +0.02%. Regarding short-term risk, CHSCN is less volatile compared to TSN. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check TSN's competition here
CHSCN vs SFD Comparison June 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 309.5M. In comparison, SFD has a market cap of 10.4B. Regarding current trading prices, CHSCN is priced at $25.19, while SFD trades at $26.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas SFD's P/E ratio is 10.28. In terms of profitability, CHSCN's ROE is +0.05%, compared to SFD's ROE of +0.15%. Regarding short-term risk, CHSCN is less volatile compared to SFD. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check SFD's competition here
CHSCN vs AGRO Comparison June 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 309.5M. In comparison, AGRO has a market cap of 6.8B. Regarding current trading prices, CHSCN is priced at $25.19, while AGRO trades at $11.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas AGRO's P/E ratio is 605.00. In terms of profitability, CHSCN's ROE is +0.05%, compared to AGRO's ROE of +0.01%. Regarding short-term risk, CHSCN is less volatile compared to AGRO. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check AGRO's competition here
CHSCN vs CALM Comparison June 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 309.5M. In comparison, CALM has a market cap of 3.5B. Regarding current trading prices, CHSCN is priced at $25.19, while CALM trades at $74.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas CALM's P/E ratio is 5.18. In terms of profitability, CHSCN's ROE is +0.05%, compared to CALM's ROE of +0.26%. Regarding short-term risk, CHSCN is less volatile compared to CALM. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check CALM's competition here
CHSCN vs IBA Comparison June 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 309.5M. In comparison, IBA has a market cap of 2.6B. Regarding current trading prices, CHSCN is priced at $25.19, while IBA trades at $53.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas IBA's P/E ratio is 7.77. In terms of profitability, CHSCN's ROE is +0.05%, compared to IBA's ROE of +0.12%. Regarding short-term risk, CHSCN is less volatile compared to IBA. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check IBA's competition here
CHSCN vs FDP Comparison June 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 309.5M. In comparison, FDP has a market cap of 1.4B. Regarding current trading prices, CHSCN is priced at $25.19, while FDP trades at $29.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas FDP's P/E ratio is 20.26. In terms of profitability, CHSCN's ROE is +0.05%, compared to FDP's ROE of +0.03%. Regarding short-term risk, CHSCN is less volatile compared to FDP. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check FDP's competition here
CHSCN vs DOLE Comparison June 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 309.5M. In comparison, DOLE has a market cap of 1.3B. Regarding current trading prices, CHSCN is priced at $25.19, while DOLE trades at $13.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas DOLE's P/E ratio is 14.99. In terms of profitability, CHSCN's ROE is +0.05%, compared to DOLE's ROE of +0.03%. Regarding short-term risk, CHSCN is less volatile compared to DOLE. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check DOLE's competition here
CHSCN vs VITL Comparison June 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 309.5M. In comparison, VITL has a market cap of 421.2M. Regarding current trading prices, CHSCN is priced at $25.19, while VITL trades at $9.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas VITL's P/E ratio is 9.45. In terms of profitability, CHSCN's ROE is +0.05%, compared to VITL's ROE of +0.14%. Regarding short-term risk, CHSCN is less volatile compared to VITL. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check VITL's competition here
CHSCN vs LND Comparison June 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 309.5M. In comparison, LND has a market cap of 374.6M. Regarding current trading prices, CHSCN is priced at $25.19, while LND trades at $3.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas LND's P/E ratio is -125.33. In terms of profitability, CHSCN's ROE is +0.05%, compared to LND's ROE of -0.02%. Regarding short-term risk, CHSCN is less volatile compared to LND. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check LND's competition here
CHSCN vs CHSCP Comparison June 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 309.5M. In comparison, CHSCP has a market cap of 338.1M. Regarding current trading prices, CHSCN is priced at $25.19, while CHSCP trades at $27.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas CHSCP's P/E ratio is N/A. In terms of profitability, CHSCN's ROE is +0.05%, compared to CHSCP's ROE of +0.05%. Regarding short-term risk, CHSCN is less volatile compared to CHSCP. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check CHSCP's competition here
CHSCN vs CHSCO Comparison June 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 309.5M. In comparison, CHSCO has a market cap of 321.4M. Regarding current trading prices, CHSCN is priced at $25.19, while CHSCO trades at $26.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas CHSCO's P/E ratio is N/A. In terms of profitability, CHSCN's ROE is +0.05%, compared to CHSCO's ROE of +0.05%. Regarding short-term risk, CHSCN is less volatile compared to CHSCO. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check CHSCO's competition here
CHSCN vs CHSCL Comparison June 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 309.5M. In comparison, CHSCL has a market cap of 316.6M. Regarding current trading prices, CHSCN is priced at $25.19, while CHSCL trades at $25.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas CHSCL's P/E ratio is N/A. In terms of profitability, CHSCN's ROE is +0.05%, compared to CHSCL's ROE of +0.05%. Regarding short-term risk, CHSCN is more volatile compared to CHSCL. This indicates potentially higher risk in terms of short-term price fluctuations for CHSCN.Check CHSCL's competition here
CHSCN vs CHSCM Comparison June 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 309.5M. In comparison, CHSCM has a market cap of 306.6M. Regarding current trading prices, CHSCN is priced at $25.19, while CHSCM trades at $24.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas CHSCM's P/E ratio is N/A. In terms of profitability, CHSCN's ROE is +0.05%, compared to CHSCM's ROE of +0.05%. Regarding short-term risk, CHSCN is more volatile compared to CHSCM. This indicates potentially higher risk in terms of short-term price fluctuations for CHSCN.Check CHSCM's competition here
CHSCN vs ALCO Comparison June 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 309.5M. In comparison, ALCO has a market cap of 299.8M. Regarding current trading prices, CHSCN is priced at $25.19, while ALCO trades at $40.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas ALCO's P/E ratio is -16.36. In terms of profitability, CHSCN's ROE is +0.05%, compared to ALCO's ROE of -0.18%. Regarding short-term risk, CHSCN is less volatile compared to ALCO. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check ALCO's competition here
CHSCN vs VFF Comparison June 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 309.5M. In comparison, VFF has a market cap of 282.3M. Regarding current trading prices, CHSCN is priced at $25.19, while VFF trades at $2.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas VFF's P/E ratio is 11.23. In terms of profitability, CHSCN's ROE is +0.05%, compared to VFF's ROE of +0.14%. Regarding short-term risk, CHSCN is less volatile compared to VFF. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check VFF's competition here
CHSCN vs AFRI Comparison June 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 309.5M. In comparison, AFRI has a market cap of 268.3M. Regarding current trading prices, CHSCN is priced at $25.19, while AFRI trades at $10.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas AFRI's P/E ratio is -22.11. In terms of profitability, CHSCN's ROE is +0.05%, compared to AFRI's ROE of +2.87%. Regarding short-term risk, CHSCN is less volatile compared to AFRI. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check AFRI's competition here
CHSCN vs LMNR Comparison June 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 309.5M. In comparison, LMNR has a market cap of 214.9M. Regarding current trading prices, CHSCN is priced at $25.19, while LMNR trades at $11.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas LMNR's P/E ratio is -9.27. In terms of profitability, CHSCN's ROE is +0.05%, compared to LMNR's ROE of -0.13%. Regarding short-term risk, CHSCN is less volatile compared to LMNR. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check LMNR's competition here
CHSCN vs AGFS Comparison June 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 309.5M. In comparison, AGFS has a market cap of 161.2M. Regarding current trading prices, CHSCN is priced at $25.19, while AGFS trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas AGFS's P/E ratio is -2.61. In terms of profitability, CHSCN's ROE is +0.05%, compared to AGFS's ROE of -0.12%. Regarding short-term risk, CHSCN is more volatile compared to AGFS. This indicates potentially higher risk in terms of short-term price fluctuations for CHSCN.Check AGFS's competition here
CHSCN vs LOCL Comparison June 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 309.5M. In comparison, LOCL has a market cap of 35.3M. Regarding current trading prices, CHSCN is priced at $25.19, while LOCL trades at $1.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas LOCL's P/E ratio is -0.85. In terms of profitability, CHSCN's ROE is +0.05%, compared to LOCL's ROE of +0.44%. Regarding short-term risk, CHSCN is less volatile compared to LOCL. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check LOCL's competition here
CHSCN vs PME Comparison June 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 309.5M. In comparison, PME has a market cap of 23.2M. Regarding current trading prices, CHSCN is priced at $25.19, while PME trades at $0.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas PME's P/E ratio is 13.50. In terms of profitability, CHSCN's ROE is +0.05%, compared to PME's ROE of -0.03%. Regarding short-term risk, CHSCN is less volatile compared to PME. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check PME's competition here
CHSCN vs AFRIW Comparison June 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 309.5M. In comparison, AFRIW has a market cap of 21.9M. Regarding current trading prices, CHSCN is priced at $25.19, while AFRIW trades at $0.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas AFRIW's P/E ratio is -35.41. In terms of profitability, CHSCN's ROE is +0.05%, compared to AFRIW's ROE of +2.87%. Regarding short-term risk, CHSCN is more volatile compared to AFRIW. This indicates potentially higher risk in terms of short-term price fluctuations for CHSCN.Check AFRIW's competition here
CHSCN vs SDOT Comparison June 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 309.5M. In comparison, SDOT has a market cap of 13M. Regarding current trading prices, CHSCN is priced at $25.19, while SDOT trades at $13.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas SDOT's P/E ratio is -0.01. In terms of profitability, CHSCN's ROE is +0.05%, compared to SDOT's ROE of +6.12%. Regarding short-term risk, CHSCN is less volatile compared to SDOT. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check SDOT's competition here
CHSCN vs APPHW Comparison June 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 309.5M. In comparison, APPHW has a market cap of 10.3M. Regarding current trading prices, CHSCN is priced at $25.19, while APPHW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas APPHW's P/E ratio is N/A. In terms of profitability, CHSCN's ROE is +0.05%, compared to APPHW's ROE of -0.55%. Regarding short-term risk, CHSCN is less volatile compared to APPHW. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check APPHW's competition here
CHSCN vs APPH Comparison June 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 309.5M. In comparison, APPH has a market cap of 10.3M. Regarding current trading prices, CHSCN is priced at $25.19, while APPH trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas APPH's P/E ratio is -0.14. In terms of profitability, CHSCN's ROE is +0.05%, compared to APPH's ROE of -0.55%. Regarding short-term risk, CHSCN is less volatile compared to APPH. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check APPH's competition here
CHSCN vs AQB Comparison June 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 309.5M. In comparison, AQB has a market cap of 3.8M. Regarding current trading prices, CHSCN is priced at $25.19, while AQB trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas AQB's P/E ratio is -0.99. In terms of profitability, CHSCN's ROE is +0.05%, compared to AQB's ROE of -3.68%. Regarding short-term risk, CHSCN is less volatile compared to AQB. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check AQB's competition here
CHSCN vs EDBLW Comparison June 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 309.5M. In comparison, EDBLW has a market cap of 2.9M. Regarding current trading prices, CHSCN is priced at $25.19, while EDBLW trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas EDBLW's P/E ratio is -0.05. In terms of profitability, CHSCN's ROE is +0.05%, compared to EDBLW's ROE of -1.39%. Regarding short-term risk, CHSCN is less volatile compared to EDBLW. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check EDBLW's competition here
CHSCN vs KALWW Comparison June 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 309.5M. In comparison, KALWW has a market cap of 2.1M. Regarding current trading prices, CHSCN is priced at $25.19, while KALWW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas KALWW's P/E ratio is N/A. In terms of profitability, CHSCN's ROE is +0.05%, compared to KALWW's ROE of -0.19%. Regarding short-term risk, CHSCN is less volatile compared to KALWW. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check KALWW's competition here
CHSCN vs KAL Comparison June 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 309.5M. In comparison, KAL has a market cap of 2.1M. Regarding current trading prices, CHSCN is priced at $25.19, while KAL trades at $1.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas KAL's P/E ratio is -0.01. In terms of profitability, CHSCN's ROE is +0.05%, compared to KAL's ROE of -0.19%. Regarding short-term risk, CHSCN is less volatile compared to KAL. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check KAL's competition here
CHSCN vs AGRI Comparison June 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 309.5M. In comparison, AGRI has a market cap of 1.9M. Regarding current trading prices, CHSCN is priced at $25.19, while AGRI trades at $0.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas AGRI's P/E ratio is 0.00. In terms of profitability, CHSCN's ROE is +0.05%, compared to AGRI's ROE of -0.92%. Regarding short-term risk, CHSCN is less volatile compared to AGRI. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check AGRI's competition here
CHSCN vs AVX Comparison June 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 309.5M. In comparison, AVX has a market cap of 1.2M. Regarding current trading prices, CHSCN is priced at $25.19, while AVX trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas AVX's P/E ratio is N/A. In terms of profitability, CHSCN's ROE is +0.05%, compared to AVX's ROE of -0.87%. Regarding short-term risk, CHSCN is less volatile compared to AVX. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check AVX's competition here
CHSCN vs AGRIW Comparison June 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 309.5M. In comparison, AGRIW has a market cap of 66.2K. Regarding current trading prices, CHSCN is priced at $25.19, while AGRIW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas AGRIW's P/E ratio is -0.01. In terms of profitability, CHSCN's ROE is +0.05%, compared to AGRIW's ROE of -0.87%. Regarding short-term risk, CHSCN is less volatile compared to AGRIW. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check AGRIW's competition here
CHSCN vs EDBL Comparison June 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 309.5M. In comparison, EDBL has a market cap of 61.8K. Regarding current trading prices, CHSCN is priced at $25.19, while EDBL trades at $0.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas EDBL's P/E ratio is N/A. In terms of profitability, CHSCN's ROE is +0.05%, compared to EDBL's ROE of -1.39%. Regarding short-term risk, CHSCN is less volatile compared to EDBL. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check EDBL's competition here
CHSCN vs AAGRW Comparison June 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 309.5M. In comparison, AAGRW has a market cap of 57.9K. Regarding current trading prices, CHSCN is priced at $25.19, while AAGRW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas AAGRW's P/E ratio is N/A. In terms of profitability, CHSCN's ROE is +0.05%, compared to AAGRW's ROE of +3.27%. Regarding short-term risk, CHSCN is less volatile compared to AAGRW. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check AAGRW's competition here
CHSCN vs SANW Comparison June 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 309.5M. In comparison, SANW has a market cap of 43.2K. Regarding current trading prices, CHSCN is priced at $25.19, while SANW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas SANW's P/E ratio is N/A. In terms of profitability, CHSCN's ROE is +0.05%, compared to SANW's ROE of -0.11%. Regarding short-term risk, CHSCN is less volatile compared to SANW. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check SANW's competition here
CHSCN vs AAGR Comparison June 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 309.5M. In comparison, AAGR has a market cap of 5.8K. Regarding current trading prices, CHSCN is priced at $25.19, while AAGR trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas AAGR's P/E ratio is N/A. In terms of profitability, CHSCN's ROE is +0.05%, compared to AAGR's ROE of +3.27%. Regarding short-term risk, CHSCN is less volatile compared to AAGR. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check AAGR's competition here
CHSCN vs DTCK Comparison June 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 309.5M. In comparison, DTCK has a market cap of 3.1K. Regarding current trading prices, CHSCN is priced at $25.19, while DTCK trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas DTCK's P/E ratio is -0.27. In terms of profitability, CHSCN's ROE is +0.05%, compared to DTCK's ROE of -1.28%. Regarding short-term risk, CHSCN is less volatile compared to DTCK. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check DTCK's competition here
CHSCN vs TSNU Comparison June 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 309.5M. In comparison, TSNU has a market cap of 0. Regarding current trading prices, CHSCN is priced at $25.19, while TSNU trades at $66.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas TSNU's P/E ratio is N/A. In terms of profitability, CHSCN's ROE is +0.05%, compared to TSNU's ROE of +0.02%. Regarding short-term risk, CHSCN is less volatile compared to TSNU. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check TSNU's competition here
CHSCN vs LOCL-WT Comparison June 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 309.5M. In comparison, LOCL-WT has a market cap of 0. Regarding current trading prices, CHSCN is priced at $25.19, while LOCL-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas LOCL-WT's P/E ratio is N/A. In terms of profitability, CHSCN's ROE is +0.05%, compared to LOCL-WT's ROE of +0.44%. Regarding short-term risk, CHSCN is less volatile compared to LOCL-WT. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check LOCL-WT's competition here
CHSCN vs OME Comparison June 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 309.5M. In comparison, OME has a market cap of 0. Regarding current trading prices, CHSCN is priced at $25.19, while OME trades at $22.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas OME's P/E ratio is N/A. In terms of profitability, CHSCN's ROE is +0.05%, compared to OME's ROE of +0.10%. Regarding short-term risk, CHSCN is more volatile compared to OME. This indicates potentially higher risk in terms of short-term price fluctuations for CHSCN.Check OME's competition here